Evidence map›Paper›PMID 42009984›Full record

ReviewMolecular psychiatry2026

Single-cell transcriptomics of human brain disorders.

Keon Arbabi, Giuseppe Carito, Tain Luquez, Michael Wainberg

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Keon Arbabi *Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.ORCID http://orcid.org/0000-0003-3219-8835
Giuseppe Carito *Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.
Tain LuquezCenter for Translational and Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Michael WainbergLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada. m.wainberg@mail.utoronto.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain disease is ultimately a disease of its constituent cells, and single-cell genomics has recently begun to illuminate the cellular pathologies underlying human brain disorders. In this review, we synthesize the key biological insights from recent single-cell studies of post-mortem human brain tissue across a range of neurological and psychiatric conditions. Organized by major central nervous system cell type, we detail the depletion of vulnerable cellular populations, the emergence of disease-associated states, the dysregulation of gene expression programs, and the interplay between these changes and genetic risk factors. Collectively, these studies mark a turning point in brain disease research, providing the first comprehensive maps of how neurological and psychiatric disorders manifest across the cellular landscape of the human brain.

Indexed as

Brain DiseasesAnimalsBrainGenomicsHumansMental DisordersSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisTranscriptome

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.